Navigation Links
U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
Date:4/8/2008

rheumatoid factor (RF) positive) and Systemic JIA with polyarticular course (20 percent) who had not responded adequately to other JIA therapies. In the first phase of this study (Period A), a total of 190 patients aged six to 17 years, with disease duration of approximately four years with moderately to severely active disease at study entry, were enrolled in this open-label, four-month, lead-in phase of the study. The majority (70 percent) of these study patients were new to biologic treatments. Nearly 30 percent of patients had previously had an inadequate response to a TNF antagonist or anakinra. Patients received ORENCIA(R) (abatacept) intravenously (10 mg/kg; maximum 1,000 mg) on Days 1, 15, 29 and every month thereafter. Response was assessed utilizing the ACR Pediatric 30 definition of improvement, defined as greater than or equal to 30 percent improvement in at least three of the six JIA core set variables and greater than or equal to 30 percent worsening in not more than one of the JIA core set variables.

In Period A of the study, ORENCIA demonstrated consistent improvement in ACR Pedi 30 with similar responses across all JIA subtypes (Oligoarticular extended, 59.3 percent; Polyarticular-RF positive, 68.4 percent; Polyarticular-RF negative 64.3 percent; and Systemic JIA with polyarticular course, 64.9 percent). In patients who were inadequate responders to DMARDs including MTX and were new to biologic treatment, ORENCIA demonstrated meaningful ACR Pedi response rates with 76 percent of patients achieving an ACR Pedi 30 response rate, 60 percent achieving an ACR Pedi 50 response rate, 36 percent achieving an ACR Pedi 70 response rate and 17 percent achieving an ACR Pedi 90 response rate. In patients who received prior biological treatment, 38.6 percent achieved an ACR Pedi 30 response rate, 24.6 percent achieved an ACR Pedi 50 response rate, 10.5 percent achieved an ACR Pedi 70 response rate and 1.8 percent achieved an ACR Pedi 90 response rate.


'/>"/>
SOURCE Bristol-Myers Squibb Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Ortho Biotech Statement on U.S. Food and Drug Administration Oncologic Drugs Advisory Committee Vote
2. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
3. Northwestern Offers Clinical Research and Regulatory Administration Graduate Certificate Program
4. Supplemental New Drug Application for PREZISTA(TM) Submitted to U.S. Food and Drug Administration
5. Biological Psychiatry Publishes Study Showing VYVANSE Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours After Administration
6. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
7. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
8. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
9. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
10. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
11. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... , March 3, 2015  UnaliWear announces the ... advanced support for seniors that guards against wandering and ... The new wearable – the Kanega watch ( ... kind to use an easy speech interface rather than ... information without human input. The watch ...
(Date:3/3/2015)... -- Columbia Laboratories, Inc. (Nasdaq: CBRX ) (" ... pharmaceutical company focused on pharmaceuticals for women,s health, today ... ROTH Conference, which will take place from March 8-11 ... Point, California . Management,s presentation will take place ... (12:00 p.m. Eastern Time) in the Promenade room. ...
(Date:3/3/2015)... , March 3, 2015  AT&T 1 ... today announced that  AT&T  is the connectivity provider for ... was designed to help provide peace of mind to ... the freedom to live active lives with the confidence ... need it. The AT&T network 2 helps power ...
Breaking Medicine Technology:UnaliWear's Wearable For Seniors Extends Independence With Advanced Technology 2AT&T Providing Connectivity for Philips GoSafe Mobile Medical Alert System, Empowering United States Seniors to be Connected to Emergency Care On-the-Go 2AT&T Providing Connectivity for Philips GoSafe Mobile Medical Alert System, Empowering United States Seniors to be Connected to Emergency Care On-the-Go 3AT&T Providing Connectivity for Philips GoSafe Mobile Medical Alert System, Empowering United States Seniors to be Connected to Emergency Care On-the-Go 4
... DUBLIN, Calif., April 14, 2011 Carl Zeiss ... microscope system at the 79th Annual Meeting of ... Denver, Colo. Based on the breakthrough OPMI® Pentero ... offers innovative new features and customer benefits such ...
... results from the largest multicenter clinical trial for heart ... International Society for Heart & Lung Transplantation (ISHLT) 31st ... show clinical benefit for the use of Everolimus in ... randomized patients at 67 medical centers spanning 5 continents. ...
Cached Medicine Technology:PENTERO 900: Elevating Excellence in Microsurgery to a New Level 2PENTERO 900: Elevating Excellence in Microsurgery to a New Level 3Results From Largest Study of Anti-Rejection Therapy for Heart Transplant Patients Will be Released at ISHLT Meeting 2Results From Largest Study of Anti-Rejection Therapy for Heart Transplant Patients Will be Released at ISHLT Meeting 3Results From Largest Study of Anti-Rejection Therapy for Heart Transplant Patients Will be Released at ISHLT Meeting 4
(Date:3/4/2015)... 04, 2015 From the halls of ... Privacy Summit 2015 , AvePoint, the established ... today introduced the AvePoint Risk Intelligence System (ARIS) ... of risk across the enterprise. , Leveraging the templates ... Impact Assessment (APIA) system – used by more ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 Professionals with ... more targeted outreach from companies, according to a new ... 2014 survey of 235 professionals with disabilities , ... online job search tools, including ones that are geared ... work. Some highlights:, ,     Online job search ...
(Date:3/4/2015)... Texas (PRWEB) March 04, 2015 ... today announced that Alan Daugherty has been named ... immediately. Daugherty has served as interim CEO of ... , “Alan has provided tremendous leadership during his ... abilities leading hospital strategy and developing relationships with ...
(Date:3/3/2015)... March 04, 2015 MED-Ed ... design and construction event for New England, April ... announced key building envelope related workshops. Sessions offer ... Workshops include: , Curtain Walls for Labs ... health care and laboratory facilities are often required ...
(Date:3/3/2015)... OH (PRWEB) March 03, 2015 On ... amended complaint in the United States District Court for ... and Financial Freedom, as well as insurance companies Balboa, ... 24, 2015 in Case No. 3:14-cv-152.) , The Plaintiff, ... with insurance companies to force her to buy too ...
Breaking Medicine News(10 mins):Health News:AvePoint Unveils New Solution to Address the Complete Risk Lifecycle at IAPP Global Privacy Summit 2015 2Health News:AvePoint Unveils New Solution to Address the Complete Risk Lifecycle at IAPP Global Privacy Summit 2015 3Health News:AvePoint Unveils New Solution to Address the Complete Risk Lifecycle at IAPP Global Privacy Summit 2015 4Health News:Job Seekers with Disabilities Seek Targeted Outreach from Employers and Online Job Search Tools, says New Think Beyond The Label Survey 2Health News:Job Seekers with Disabilities Seek Targeted Outreach from Employers and Online Job Search Tools, says New Think Beyond The Label Survey 3Health News:Alan Daugherty Named CEO of Parkview Regional Hospital and Ennis Regional Medical Center 2Health News:Alan Daugherty Named CEO of Parkview Regional Hospital and Ennis Regional Medical Center 3Health News:Building Envelope Code and Regulation Sessions at MED-Ed Facilities 2Health News:Building Envelope Code and Regulation Sessions at MED-Ed Facilities 3Health News:Building Envelope Code and Regulation Sessions at MED-Ed Facilities 4Health News:Building Envelope Code and Regulation Sessions at MED-Ed Facilities 5Health News:Building Envelope Code and Regulation Sessions at MED-Ed Facilities 6Health News:Borrower Accuses Mortgage Lenders of Racketeering in Forcing Insurance on Homeowners 2
... 29 Several individuals,and organizations were honored at ... Association (NJHA) today at the Hyatt Regency Princeton., ... to George F.,Lynn, former chief executive officer of ... honored for his years of service and leadership ...
... March for Babies 2008 Official Shoes are Now On Sale, ... has teamed up with Famous Footwear(TM) and Dr. Scholl,s(R) to,introduce ... the third consecutive year, Famous Footwear and Dr. Scholl,s are,raising ... shoe styles.,Dr. Scholl,s specially designed one men,s and two women,s ...
... German . , Davos/Leipzig. For countries without their ... can be useful for working out where there is ... within the European Union there are more suitable instruments ... a study conducted by the Helmholtz Centre for Environmental ...
... Feb. 29 Children,s Healthcare of Atlanta, one,of ... a,landmark investment in the future of pediatric research ... million of the Children,s,endowment toward pediatric research., ... be,invested in pediatric research," said James E. Tally, ...
... be Affected Nationwide, Study ... Expects, ... states that a little known,anti-privatization measure in the current farm bill would ... an amendment to the House-passed Farm Bill by Rep. Joe,Baca (D-CA), would ...
... Affected Nationwide, Study ... Expects, ... that a little known,anti-privatization measure in the current farm bill would critically ... as an amendment to the House-passed Farm,Bill by Rep. Joe Baca (D-CA), ...
Cached Medicine News:Health News:New Jersey Hospital Association Presents Awards for Commitment to Healthcare 2Health News:New Jersey Hospital Association Presents Awards for Commitment to Healthcare 3Health News:Famous Footwear, Dr. Scholl's Step Up to Support March for Babies 2008 2Health News:Lumping different countries together -- why the 2008 EPI is of limited use 2Health News:Lumping different countries together -- why the 2008 EPI is of limited use 3Health News:Children's Healthcare of Atlanta Announces Major Investment in Pediatric Research as Part of 10-Year Vision 2Health News:Children's Healthcare of Atlanta Announces Major Investment in Pediatric Research as Part of 10-Year Vision 3Health News:Farm Bill Provision Will Disrupt Kentucky Medical Program 2Health News:Farm Bill Provision Will Disrupt Kentucky Medical Program 3Health News:Farm Bill Provision Will Disrupt Food Stamp and Medicaid Programs 2Health News:Farm Bill Provision Will Disrupt Food Stamp and Medicaid Programs 3
... disposable 0.5mL PYREX glass pipets ... with blow-out and offer long, ... pipetting go faster and easier. ... and fire polished tips for ...
... surgeon and O.R. staff work hard to ... fluid intravasation. Manual methods are complicated, time-consuming, ... DOLPHIN II Fluid Management System for hysteroscopy, ... endoscopic irrigation. It has been developed to ...
... These 3mL PYREX volumetric ... A tolerances in accordance with ... Each pipet is individually serialized ... of Identification and Capacity, traceable ...
... These precision 4mL PYREX ... calibrated "To Contain" (TC - ... (TD - top line) to ... ware. Pipets are color-coded with ...
Medicine Products: